Last updated: December 3, 2024
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dry Eye Disease
Dry Eyes
Treatment
N/AClinical Study ID
NCT06714799
DER-OCCHI-19-01
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patients who had been diagnosed with one of the following conditions in the ocularand periocular region: common melanocytic nevus, melanosis, seborrheic keratosis,viral wart, angioma and angiokeratoma, apocrine hydrocystoma, xanthelasma,steatocystoma, actinic keratosis, basal cell carcinoma, squamous cell carcinoma,melanoma.
Exclusion
Exclusion Criteria:
- Patients who presented with one of the following conditions were excluded from thestudy: concomitant inflammatory processes, including blepharitis, chalazion,pterygium, pinguecula), coexistence of multiple, periocular or ocular lesions,diagnosis of syndromic diseases related to a major risk for cutaneous neoformations.
Study Design
Total Participants: 300
Study Start date:
June 15, 2021
Estimated Completion Date:
December 15, 2030
Study Description
Connect with a study center
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, 40138
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.